Ledger.Open graph →
SEC Form D · Amendment · filed May 7, 2009

SYNAGEVA BIOPHARMA CORP

Offering
$45.0M
Sold
$33.1M
Exemption
—
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

People & firms on this filing (14)

Thomas Malley · Waltham, MADirectorFelix Baker · Waltham, MADirectorLyle Hohnke · Waltham, MADirectorStephen Biggar · Waltham, MADirectorSanj K. Patel · Waltham, MAExec · DirectorRobyn Samuels · Waltham, MADirectorMark Goldberg · Waltham, MADirectorJames Rogers · San Mateo, CAExec · DirectorLou Salfi · San Mateo, CADirectorChristofer Schneider · San Mateo, CADirectorJohn Battendieri · Aptos, CADirectorJaap Langenberg · Aptos, CADirectorTimothy Redmond · Aptos, CADirectorMark A. Retzloff · Boulder, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗